CClinicalTrials.gg
Status unknownNCT04953676Updated Jul 8, 2021

A Clinical Trial of the Round-tunnel and Flat-tunnel Technique of ACL Reconstruction

An interventional study of round tunnel technique and flat tunnel technique in Anterior Cruciate Ligament Rupture, sponsored by Peking University Third Hospital. Status unknown. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2021-07-08.

Sponsored by Peking University Third Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study intends to perform round-tunnel and flat-tunnel ACL reconstruction technique in 144 patients, and compare the clinical outcomes of the two surgical procedures through follow-up.

Read the detailed description

This is a prospective randomized, controlled, multi-center clinical trial study on ACL reconstruction surgery technique. It is jointly undertaken by the Peking University Third Hospital, Nanjing Drum Tower Hospital, Zhengzhou Orthopaedic Hospital, and Shenzhen Second People's Hospital. Peking University Third Hospital is the team leader unit. In this study, 144 patients with ACL rupture were recruited according to the enrollment criteria. Among them, 54 patients with ACL rupture were recruited and carried out by the Peking University Third Hospital. The recruited patients were randomly divided into groups. The ratio of the control group is 1:1. Each of the other three hospitals recruited 30 patients and randomly grouped them according to the same enrollment criteria. The ratio of the experimental group to the control group was also 1:1. In this study, 72 patients with ACL rupture in the experimental group will be treated with flat-tunnel reconstruction technique, and 72 patients with ACL rupture in the control group will be treated with round-tunnel technique. All operations will be performed with autologous hamstring tendons. After reconstruction, all subjects will participate in the collection of clinical function scores including Tegner score, Lysholm score, IKDC score, and clinical evaluation including physical examination, joint laxity, CT and MRI imaging analysis to verify ACL Advantages of flat-tunnel technique.

02

Conditions studied

  • Anterior Cruciate Ligament Rupture

Browse trials for

03

In context

Rupture

557 studies on the registry are indexed under Rupture; 97 are open to participants now.

This study's planned enrollment of 144 is above the median of 72 across 334 interventional studies indexed under Rupture.

Browse Rupture studies →

Lead sponsor

Peking University Third Hospital is the lead sponsor of 735 studies on the registry; 262 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • For the first time, the knee joint simply ruptures the anterior cruciate ligament (ACL) and requires surgical reconstruction; it can be combined with meniscus injury, and the Outerbridge injury score is ≤ Grade II; There is no history of trauma or fracture of the ipsilateral knee joint; Posterior Cruciate Ligament (PCL) has no damage; Medial Collateral Ligament (MCL) or Lateral collateral ligaments (LCL) has no damage or only slight damage (no more than I degree).

Exclusion criteria

Exclusion Criteria:

  • BMI is less than 18.5 or greater than 35 kg/m2; Patients with moderate or severe knee degeneration; Those with limited flexion angle (\<120 degrees); The cartilage defect area is greater than 2 cm2 or the Outerbridge damage score is> Grade II.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
144 participants (estimated)

Study arms

  • Other
    Control Group

    round tunnel

    Procedure: round tunnel technique

  • Experimental
    Experimental group

    flat tunnel

    Procedure: flat tunnel technique

Interventions

  • Procedureround tunnel technique

    Both the femoral tunnel and tibial tunnel were drilled by 8-mm cannulated drill

  • Procedureflat tunnel technique

    Both the femoral tunnel and tibial tunnel were dimension of 5×11-mm rounded-rectangular, which was created by initially drilling a round tunnel with a 5-mm cannulated drill and reshaped by use of a bone rasp and custom-made dilator.

06

What researchers measure

Primary outcomes

  1. KT-2000

    side-to-side difference

    Time frame: 6 months, 12 months, 24 months

Secondary outcomes

  1. Tegner Score

    functional scores

    Time frame: 6 months, 12 months, 24 months

  2. Lysholm Score

    functional scores

    Time frame: 6 months, 12 months, 24 months

  3. IKDC Score

    functional scores

    Time frame: 6 months, 12 months, 24 months

  4. Lachman test

    physical examination

    Time frame: 6 months, 12 months, 24 months

  5. Pivot-shift test

    physical examination

    Time frame: 6 months, 12 months, 24 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04953676
Lead sponsor
Peking University Third Hospital
Collaborators
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Zhengzhou Orthopaedic Hospital, Shenzhen Second People's Hospital
Responsible party
Sponsor
First posted
Jul 8, 2021
Start date
Sep 1, 2021 (estimated)
Primary completion
Sep 1, 2022 (estimated)
Completion
Sep 1, 2024 (estimated)
Last update
Jul 8, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion